| 000 | 01726 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517173637.0 | ||
| 264 | 0 | _c20180611 | |
| 008 | 201806s 0 0 eng d | ||
| 022 | _a2164-554X | ||
| 024 | 7 |
_a10.1080/21645515.2017.1342908 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCapeding, Maria Rosario Z | |
| 245 | 0 | 0 |
_aSafety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines. _h[electronic resource] |
| 260 |
_bHuman vaccines & immunotherapeutics _c10 2017 |
||
| 300 |
_a2232-2239 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase IV; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntibodies, Bacterial _xblood |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCholera _xepidemiology |
| 650 | 0 | 4 |
_aCholera Vaccines _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunogenicity, Vaccine |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPhilippines _xepidemiology |
| 650 | 0 | 4 | _aSeroconversion |
| 650 | 0 | 4 | _aVaccination |
| 650 | 0 | 4 |
_aVaccines, Inactivated _xadministration & dosage |
| 650 | 0 | 4 |
_aVibrio cholerae O1 _ximmunology |
| 700 | 1 | _aGonzales, Maria Liza Antoinette M | |
| 700 | 1 | _aDhingra, Mandeep Singh | |
| 700 | 1 | _aD'Cor, Naveena Aloysia | |
| 700 | 1 | _aMidde, Venkat Jayanth | |
| 700 | 1 | _aPatnaik, Badri Narayan | |
| 700 | 1 | _aThollot, Yaël | |
| 700 | 1 | _aDesauziers, Eric | |
| 773 | 0 |
_tHuman vaccines & immunotherapeutics _gvol. 13 _gno. 10 _gp. 2232-2239 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/21645515.2017.1342908 _zAvailable from publisher's website |
| 999 |
_c27565325 _d27565325 |
||